Journal of Parkinson's Disease

Share Us: Subscribe | Contact

User Top Menu

JPD 12:1 review #1: Pathogens and Anti-Infective Agents

JPD 11:s2 OA special issue (Repairing the Parkinsonian Brain)

New Co-Editor-in-Chief Appointed
Lorraine V. Kalia, MD, PhD, FRCPC, an Associate Professor and Clinician Scientist in the Division of Neurology at the University of Toronto and a Senior Scientist at the Krembil Research Institute of the University Health Network, joins JPD! Click for details.

Role of Parkinson Nurses (PN) for Personalizing PD CareAuthors Marlena van Munster et al. outline important functions that nurses fulfil in personalized PD care, with a call for clear role definition to adjust training for PN across healthcare systems. Published in: J. Parkinsons Dis., Vol. 12:6, 2022.

Clinical Trial Pipeline: 2022 Update
Authors Kevin McFarthing et al. provide an overview of the pharmacological therapies in clinical trials for PD during 2021–2022. Published in: J. Parkinsons Dis., Vol. 12:4, 2022.

View open access commentary
Authors Richard K. Wyse et al. comment in this article about Parkin Interacting Substrate (PARIS) and consider next steps for evaluating possible long-term PD patient benefits. Published in: J. Parkinsons Dis., Vol. 12:1, 2022.

View open access review
Discover the PD prevention agenda in this review by Briana R. De Miranda et al. that considers areas of inquiry and funding & policy changes necessary to help prevent the world’s fastest growing brain disease. Published in: J. Parkinsons Dis., Vol. 12:1, 2022.

View open access review
This review by Si Shen et al. summarizes the current evidence for the association between infective pathogens and Parkinson’s disease. Published in: J. Parkinsons Dis., Vol. 12:1, 2022.

Watch the Webinar Rercording
Hosted by JPD, Parkinson's Movement and CPT, the "Deep Brain Stimulation" webinar took place on Dec 8, 2021. Click on the image to view the recording on the IOS Press YouTube channel! Read more about this webinar series here

View open access special issue
This issue, edited by Anders Björklund, Bas Bloem, Patrik Brundin, and Howard Federoff, explores novel treatment modalities that show promise for blocking disease progression and restoring normal function. Click image to view issue & read the press release here

How I Examine My Patient

The Shaking Shoelace

Clinical Application of Brain MRI in the Diagnostic Work-up of Parkinsonism

The Clinical Evaluation of Parkinson’s Tremor

Clinical Trial Highlights: Individual Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of K0706 in Subjects With Early Parkinson’s Disease

A phase 3, 4-week, multicentre (130 loca-tions), randomized, double-blind, placebo-control-led, parallel-group study of TD-9855 in treating symptomatic neurogenic orthostatic hypotension in subjects with primary autonomic failure

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects

Most Popular Articles

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update

The Emerging Evidence of the Parkinson Pandemic

Urinary Tract Infection in Parkinson’s Disease

Parkinson’s Disease in Women and Men: What’s the Difference?

Latest Articles

A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies (Open Access)

Parkinsonism-Hyperpyrexia Syndrome and Dyskinesia-Hyperpyrexia Syndrome in Parkinson’s Disease: Two Cases and Literature Review (Open Access)

Association Between Parkinson’s Disease and Coronary Artery Disease: A Systematic Review and Meta-Analysis

Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson’s Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis

Effects of Resistance Training on Motor- and Non-Motor Symptoms in Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis

Tweets by journal_PD

Watch the latest recording of our Quarterly Parkinson's Webinars by clicking above or here, and discover all about the webinar series & watch all recordings here!

1 December 2022

Growing Evidence for the Role of the Immune System in Parkinson’s Disease

Amsterdam, NL – In this special supplement to the Journal of Parkinson’s Disease, “The Immune System in Parkinson’s Disease,” experts highlight the latest research breakthroughs on the links between immune activation and neuroinflammation and Parkinson’s disease (PD) and discuss the challenges and novel therapeutic strategies targeting the immune system with the hope of reducing or reversing neurodegeneration.

Comment

Bookmark

Comment

| Bookmark | | Follow